4-Hydroxy Solifenacin-d5

4-Hydroxy Solifenacin-d5 is a chemical compound that is used in the treatment of overactive bladder syndrome. Overactive bladder syndrome is a condition where the bladder muscles contract uncontrollably, leading to frequent urination, urgency, and incontinence. Solifenacin-d5 is a well-known medication that is used to treat this condition, and 4-Hydroxy Solifenacin-d5 is one of its metabolites. The chemical name of 4-Hydroxy Solifenacin-d5 is (1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid 4-(diethylamino)-2-hydroxybenzylidenehydrazide. It is a derivative of Solifenacin-d5, which is a selective muscarinic antagonist. This means that it blocks the action of acetylcholine, a neurotransmitter that stimulates the contraction of the bladder muscles. Thus, 4-Hydroxy Solifenacin-d5 helps to relax the bladder muscles, reducing the frequency of urination and urgency. The pharmacological properties of 4-Hydroxy Solifenacin-d5 have been extensively studied, and it has been found to have high binding affinity to the muscarinic receptors, particularly the M3 subtype. It has a longer half-life than Solifenacin-d5, which means that it stays in the body for a longer time, providing sustained therapeutic effects. In conclusion, 4-Hydroxy Solifenacin-d5 is an important metabolite of Solifenacin-d5 that is used in the treatment of overactive bladder syndrome. Its pharmacological properties make it an effective medication for reducing the symptoms associated with this condition.